SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-067343
Filing Date
2021-05-17
Accepted
2021-05-17 07:12:57
Documents
3
Period of Report
2021-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116605d1_8k.htm 8-K 29759
2 EXHIBIT 99.1 tm2116605d1_ex99-1.htm EX-99.1 14118
3 GRAPHIC tm2116605d1_ex99-1img001.jpg GRAPHIC 4117
  Complete submission text file 0001104659-21-067343.txt   50950
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 21927524
SIC: 2834 Pharmaceutical Preparations